Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

49 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q2 2019.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21.4M shares of 266M outstanding shares and own 8.03% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (11.6M shares), Capital World Investors (1.67M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.18M shares), Polygon Management Ltd. (1M shares), MILLENNIUM MANAGEMENT LLC (768K shares), Cormorant Asset Management, LP (700K shares), Alphabet Inc. (699K shares), MARSHALL WACE, LLP (515K shares), Artal Group S.A. (500K shares), and Capital International Investors (489K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.